Citigroup’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
Citigroup's IDXX Position: Q1 2026 in Review
Citigroup increased its Idexx Laboratories (IDXX) stake by 2.8% in Q1 2026, buying an estimated $2.1M and bringing the position to 120,283 shares worth $67.6M. The position accounts for 0.03% of the portfolio, ranked #535.
Citigroup first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $92.3M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Citigroup held 120,283 shares of Idexx Laboratories worth $67.6M as of Q1 2026.
- Citigroup bought 3,276 Idexx Laboratories shares in Q1 2026, an estimated $2.1M.
- Idexx Laboratories made up 0.03% of Citigroup's portfolio in Q1 2026, its #535 holding.
- Citigroup first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Idexx Laboratories position peaked at $92.3M in Q3 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.